This brief review examines the history of the intraurethral (IU) pharmacoth
erapy for the treatment of erectile dysfunction (ED). Emphasis is placed on
the design, study endpoints and results of a limited number of clinical tr
ials undertaken with PGE(1)-MUSE to demonstrate the efficacy of this unique
delivery system. Next, the theory of the iontophoretic technique of drug d
elivery is discussed. Clinical data collected while applying these methods
are presented, but are thus far limited to treatment of patients with Peyro
nie's disease. Iontophoresis as a drug delivery alternative may gain popula
rity with ED patients who fail other types of therapy or in patients with o
ther penile disorders.